A focused assessment for sponsors that need to know whether an RWE question is feasible, where the required patients and data may exist, what gaps must be addressed and what a full evidence project should cost.
Share what you know today. We work from your criteria to scope the evidence opportunity.
Therapy or device, disease area, lifecycle stage and target population.
Outcomes, safety, effectiveness, access, utilization and unmet need.
Diagnoses, treatments, labs, imaging, biomarkers and patient outcomes.
Regulatory, medical affairs, HEOR, market access and target countries.
Each assessment moves from where the data is, to whether it is fit for purpose, to how to run the study.
Target population definition, estimated availability and candidate data custodians.
Variable availability, longitudinal depth, coding, completeness, quality and major gaps.
Fit-for-purpose study concept, endpoints, comparison strategy and analytical pathway.
Governance considerations, participating institutions, timeline, scope and full-project budget.
Each engagement is a custom proposal based on scope. Scope and data-custodian compensation are finalized before each phase.
One product or indication; cohort, institution and data assessment; evidence concept; gaps, roadmap and budget.
Aggregated population profile, treatment pathways, outcomes, subgroup analysis and research-ready variable assessment.
Custom longitudinal study, federated analysis, dashboard, evidence package or governed multi-institution data access.
Share the product, indication, evidence questions, required variables, geography and intended decision.